Business Segments · Goodwill
Biotechnology — Goodwill
Danaher Biotechnology — Goodwill increased by 0.7% to $23.31B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $21.44B to $23.31B. Over 2 years (FY 2023 to FY 2025), Biotechnology — Goodwill shows relatively stable performance with a 2.1% CAGR.
Analysis
StatementSegment
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
Large balances indicate a history of significant acquisitions; changes signal currency fluctuations or impairment.
Detailed definition
The premium paid over the fair value of net assets during the acquisition of businesses integrated into the biotechnolog...
Peer comparison
Common in companies with aggressive M&A-based growth strategies.
Metric ID:
dhr_segment_biotechnology_goodwillHistorical Data
15 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $21.00B | $22.09B | $22.17B | $21.92B | $21.64B | $22.48B | $21.89B | $21.88B | $22.53B | $21.44B | $22.32B | $23.14B | $23.15B | $23.31B |
| QoQ Change | — | — | +5.2% | +0.4% | -1.1% | -1.3% | +3.9% | -2.6% | -0.1% | +3.0% | -4.9% | +4.1% | +3.7% | +0.0% | +0.7% |
| YoY Change | — | — | — | — | — | +3.1% | +1.8% | -1.2% | -0.2% | +4.1% | -4.6% | +1.9% | +5.8% | +2.7% | +8.8% |
Range$0.00 – $23.31B
Avg YoY Growth+2.2%
Median YoY Growth+2.3%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — goodwill?
- Danaher (DHR) reported biotechnology — goodwill of $23.31B in Q4 2025.
- How has Danaher's biotechnology — goodwill changed year-over-year?
- Danaher's biotechnology — goodwill increased by 8.8% year-over-year, from $21.44B to $23.31B.
- What is the long-term trend for Danaher's biotechnology — goodwill?
- Over 2 years (2023 to 2025), Danaher's biotechnology — goodwill has grown at a 2.1% compound annual growth rate (CAGR), from $88.21B to $91.91B.
- What does biotechnology — goodwill mean?
- The value of intangible assets like brand and synergy from past acquisitions in the biotechnology segment.